16-88835188-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000512.5(GALNS):​c.898+25C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0559 in 1,561,024 control chromosomes in the GnomAD database, including 2,900 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.052 ( 271 hom., cov: 32)
Exomes 𝑓: 0.056 ( 2629 hom. )

Consequence

GALNS
NM_000512.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.987

Publications

5 publications found
Variant links:
Genes affected
GALNS (HGNC:4122): (galactosamine (N-acetyl)-6-sulfatase) This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]
GALNS Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 4A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 16-88835188-G-C is Benign according to our data. Variant chr16-88835188-G-C is described in ClinVar as Benign. ClinVar VariationId is 256338.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0742 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000512.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNS
NM_000512.5
MANE Select
c.898+25C>G
intron
N/ANP_000503.1
GALNS
NM_001323544.2
c.916+25C>G
intron
N/ANP_001310473.1
GALNS
NM_001323543.2
c.343+25C>G
intron
N/ANP_001310472.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNS
ENST00000268695.10
TSL:1 MANE Select
c.898+25C>G
intron
N/AENSP00000268695.5
GALNS
ENST00000562593.5
TSL:1
n.4307+25C>G
intron
N/A
GALNS
ENST00000562931.5
TSL:5
n.486+25C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0517
AC:
7862
AN:
152162
Hom.:
270
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0416
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.0497
Gnomad ASJ
AF:
0.120
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0807
Gnomad FIN
AF:
0.0228
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.0606
Gnomad OTH
AF:
0.0602
GnomAD2 exomes
AF:
0.0538
AC:
9208
AN:
171058
AF XY:
0.0570
show subpopulations
Gnomad AFR exome
AF:
0.0475
Gnomad AMR exome
AF:
0.0354
Gnomad ASJ exome
AF:
0.123
Gnomad EAS exome
AF:
0.000311
Gnomad FIN exome
AF:
0.0228
Gnomad NFE exome
AF:
0.0609
Gnomad OTH exome
AF:
0.0628
GnomAD4 exome
AF:
0.0564
AC:
79395
AN:
1408744
Hom.:
2629
Cov.:
32
AF XY:
0.0579
AC XY:
40275
AN XY:
695810
show subpopulations
African (AFR)
AF:
0.0440
AC:
1422
AN:
32300
American (AMR)
AF:
0.0412
AC:
1510
AN:
36672
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
3168
AN:
25296
East Asian (EAS)
AF:
0.0000813
AC:
3
AN:
36882
South Asian (SAS)
AF:
0.0818
AC:
6568
AN:
80268
European-Finnish (FIN)
AF:
0.0233
AC:
1160
AN:
49718
Middle Eastern (MID)
AF:
0.110
AC:
628
AN:
5704
European-Non Finnish (NFE)
AF:
0.0569
AC:
61599
AN:
1083488
Other (OTH)
AF:
0.0571
AC:
3337
AN:
58416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
3889
7778
11666
15555
19444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2326
4652
6978
9304
11630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0516
AC:
7863
AN:
152280
Hom.:
271
Cov.:
32
AF XY:
0.0505
AC XY:
3758
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0416
AC:
1727
AN:
41558
American (AMR)
AF:
0.0495
AC:
758
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
415
AN:
3470
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5176
South Asian (SAS)
AF:
0.0808
AC:
389
AN:
4816
European-Finnish (FIN)
AF:
0.0228
AC:
242
AN:
10618
Middle Eastern (MID)
AF:
0.170
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
0.0607
AC:
4126
AN:
68022
Other (OTH)
AF:
0.0596
AC:
126
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
368
737
1105
1474
1842
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0359
Hom.:
38
Bravo
AF:
0.0521
Asia WGS
AF:
0.0310
AC:
108
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 24, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Feb 03, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mucopolysaccharidosis, MPS-IV-A Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.056
DANN
Benign
0.46
PhyloP100
-0.99
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113936280; hg19: chr16-88901596; API